No products in the cart.

Description
PRODUCT DESCRIPTION:
Etoposide is a semi-synthetic derivative of podophyllotoxin and a topoisomerase II inhibitor used in the treatment of various malignancies.
It acts by inhibiting DNA re-ligation, leading to errors in DNA synthesis and cell cycle arrest.
Packaged in a ready-to-administer pre-filled syringe, this presentation offers accuracy, sterility, and ease of use in clinical oncology settings.
Formulation & Presentation:
- Dosage Form: Sterile Injectable
- Presentation: Both in Lyophilized & Pre-Filled Syringe (customizable as per market demand)
- Available Strengths:
- 100 MG/5 ML
- Route of Administration: Intravenous or as per clinical indication and severity. Reconstituted as per protocol Intravenous infusion. To be administered under supervision of a qualified oncologist. (As per physician’s discretion or decision)
Therapeutic Indications:
Indicated as a part of combination chemotherapy regimens for:
- Small Cell Lung Cancer (SCLC)
- Testicular Cancer
- Non-Hodgkin’s Lymphoma
- Acute Myeloid Leukemia (AML)
- Ovarian Cancer and other solid tumors (as per protocol)
Side Effects:
- COMMON:
- Nausea, vomiting
- Bone marrow suppression
- Alopecia
- Fatigue
- Mucositis
- SERIOUS (RARE):
- Anaphylactic reactions
- Secondary leukemia
- Hypotension (if administered too rapidly)
- Hepatotoxicity
- PRECAUTIONS:
- Administer under strict medical supervision in a hospital or oncology setup
- Monitor blood counts regularly
- Adjust dose in renal or hepatic impairment
- Use proper PPE while handling due to cytotoxic nature
- Ensure cold chain integrity throughout the supply and use cycle
Be the first to review “Etoposide 100 MG/5 ML Pre-Filled Syringe”
TECHNICAL INFORMATION
Product Specifications
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: (15 x 1 x 8 CMS)
- Shelf Life: 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications
- Storage: Store below 2°C–8°C (Do not freeze). Requires cold-chain logistics. Protect from moisture and direct sunlight. Use strictly as per label guidelines.
Regulatory Status & Supply Information
- Regulatory Status: WHO-GMP Compliant Manufacturing. Further certifications available on request
- Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
- Stability: Compliant
- MOQ: Negotiable, based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Government Health Agencies & Oncology Hospitals
- Cancer Treatment Foundations and NGOs
- Humanitarian Aid Programs
- Pharmaceutical Distributors Specializing in Oncology
- Institutional Buyers in LATAM, Africa, South Asia, and Eastern Europe
- Partners seeking ready-to-administer PFS cytotoxic injectables with quality assurance and export documentation
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation support for effective registration
- Trusted consortium network simplifying India’s pharma supply chain
- Multiple approved manufacturers for best fit in import country
- Network of audited, compliant manufacturers across India
- Customizable & flexible branding, packaging & formulation options
- End-to-end logistics support & flexibility
- Deep expertise in exporting specialty injectables & oncology products
Contact Details
- Email: hello@pharmet.io
- Phone/WhatsApp: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.